Benzinga | Jul 28, 2021 10:58AM EDT

Asensus Surgical Stock Gains On FDA Approval For Articulating Instruments For Its Surgical System

Asensus Surgical Inc (NYSE:ASXC) has received FDA 510(k) clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform.

* Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom.

* These instruments have previously received CE Mark for use in the European Union.

* Asensus' Senhance Surgical System is a digital laparoscopic platform that leverages augmented intelligence.

* Articulating instruments are the latest addition to the Senhance Surgical System, further enhancing surgical performance with robotic precision.

* Price Action: ASXC shares are up 8.56% at $2.35 during the market session on the last check Wednesday.

* Related content: Benzinga's Full FDA Calendar.